The combination of low molecular weight heparin and deoxycholic acid (LHbisD4) has demonstrated efficacy in reducing tumor lymphatic metastasis by inhibiting VEGF-C induced lymphangiogenesis, and it exhibits low toxicity and oral bioactivity [128]. This evidence concerns the gene VEGFC and neoplasm.